Improving the Benefit versus Risk of Medicinal Products in Asia

Improving the Benefit versus Risk of Medicinal Products in Asia
The International Society of Pharmacovigilance (ISoP) has set up a Special Interest Group (SiG) on Risk Minimisation Methods for Asian Countries, aimed at elaborating novel risk-proportionate methods suitable for Asian countries with diverse health care systems, medical cultures, practices and resources. To learn about the aims and activities of this group, we spoke to Dr. J. Christophe Delumeau, one of its leading coordinators.

Please note: That all fields marked with an asterisk (*) are required.